MALA — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Metformin-associated lactic acidosis
Severe lactic acidosis (type B) with AKI reducing metformin clearance causing accumulation is metformin-associated lactic acidosis (MALA). Metformin inhibits mitochondrial complex I, promoting anaerobic metabolism. MALA is rare but has ~50% mortality. Treatment: cease metformin, aggressive IV resuscitation, sodium bicarbonate for pH <7.0, and haemodialysis (removes metformin AND corrects acidosis). Metformin is dialysable. Prevention: withhold metformin when eGFR <30 or during acute illness with dehydration risk.
Reference: AMH – 2025 – Metformin; eTG Endocrine 2024